“…Activity-dependent mediators derived from the three cells of the synapse cross the extracellular cleft in all directions to generate signals in target metabotropic receptors. In the NMJ, there are other purinergic receptors apart from AR ( Tsim and Barnard, 2002 ; Todd and Robitaille, 2006 ), several mAChR ( Santafé et al, 2007 , 2009 ; Wright et al, 2009 ; Garcia et al, 2010b ), neurotrophin receptors ( Gonzalez et al, 1999 ; Garcia et al, 2011 ; Santafé et al, 2015 ; Nadal et al, 2016a , b ) cytokine receptors ( Ribchester et al, 1998 ; Wang et al, 2002 ; Garcia et al, 2010a , 2012 ), calcitonin gene-related peptide receptors ( Changeux et al, 1992 ; Lu and Fu, 1995 ; Gaydukov et al, 2016 ), glutamate receptors ( Thomas and Sigrist, 2012 ; Personius et al, 2016 ; Tsentsevitsky et al, 2017 ) and neuregulin receptors ( Loeb, 2003 ; Kummer et al, 2006 ; Simeone et al, 2010 ; Schmidt et al, 2011 ; Wang et al, 2017 ). The way a synapse operates is largely the outcome of the confluence of several signaling pathways on intracellular kinases, which phosphorylate protein targets and materialize adaptive changes to modulate transmitter release and the stability of the connection.…”